These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3414598)

  • 1. Flow cytometric analysis of ploidy in immunohistochemically confirmed examples of malignant epithelial mesothelioma.
    Frierson HF; Mills SE; Legier JF
    Am J Clin Pathol; 1988 Sep; 90(3):240-3. PubMed ID: 3414598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant mesothelioma: immunohistochemistry and DNA ploidy analysis as methods to differentiate mesothelioma from benign reactive mesothelial cell proliferation and adenocarcinoma in pleural and peritoneal effusions.
    Friedman MT; Gentile P; Tarectecan A; Fuchs A
    Arch Pathol Lab Med; 1996 Oct; 120(10):959-66. PubMed ID: 12046609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparameter flow cytometric DNA analysis of effusions: a prospective study of 36 cases compared with routine cytology and immunohistochemistry.
    Joseph MG; Banerjee D; Harris P; Gibson S; McFadden RG
    Mod Pathol; 1995 Aug; 8(6):686-93. PubMed ID: 8532707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytology, immunopathology and flow cytometry in the diagnosis of pleural and peritoneal effusions.
    Croonen AM; van der Valk P; Herman CJ; Lindeman J
    Lab Invest; 1988 Jun; 58(6):725-32. PubMed ID: 3288807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of ploidy in solid neoplasms: comparison of fresh tissues with formalin-fixed paraffin-embedded specimens.
    Frierson HF
    Hum Pathol; 1988 Mar; 19(3):290-4. PubMed ID: 2450060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic importance of the DNA ploidy pattern in malignant mesothelioma of the pleura.
    Dejmek A; Strömberg C; Wikström B; Hjerpe A
    Anal Quant Cytol Histol; 1992 Jun; 14(3):217-21. PubMed ID: 1418271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA ploidy, S-phase, and Ki-67 antigen expression in the evaluation of cell content of pleural effusions.
    Sikora J; Dworacki G; Zeromski J
    Lung; 1996; 174(5):303-13. PubMed ID: 8843056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of DNA and karyotype ploidy in malignant mesothelioma.
    Pyrhönen S; Tiainen M; Rautonen J; Tammilehto L; Laasonen A; Mattson K; Knuutila S
    Cancer Genet Cytogenet; 1992 May; 60(1):8-13. PubMed ID: 1591710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL; Luo I; Mikhail N; Rasková J; Raska K
    Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelioid pleural mesotheliomas and pulmonary adenocarcinomas: a comparative DNA flow cytometric study.
    el-Naggar AK; Ordonez NG; Garnsey L; Batsakis JG
    Hum Pathol; 1991 Oct; 22(10):972-8. PubMed ID: 1842386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy analysis of pleural mesotheliomas: its usefulness for their distinction from lung adenocarcinomas.
    Esteban JM; Sheibani K
    Mod Pathol; 1992 Nov; 5(6):626-30. PubMed ID: 1369798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of conventional cytology, immunocytochemistry, and flow cytometric DNA ploidy in the evaluation of body cavity fluids: a prospective study of 52 patients.
    Chen LM; Lazcano O; Katzmann JA; Kimlinger TK; Li CY
    Am J Clin Pathol; 1998 Jun; 109(6):712-21. PubMed ID: 9620028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions.
    Carrillo R; Sneige N; el-Naggar AK
    Acta Cytol; 1994; 38(3):367-72. PubMed ID: 8191825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localized malignant mesothelioma. A clinicopathologic and flow cytometric study.
    Crotty TB; Myers JL; Katzenstein AL; Tazelaar HD; Swensen SJ; Churg A
    Am J Surg Pathol; 1994 Apr; 18(4):357-63. PubMed ID: 7511353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric analysis of malignant pleural mesotheliomas.
    Burmer GC; Rabinovitch PS; Kulander BG; Rusch V; McNutt MA
    Hum Pathol; 1989 Aug; 20(8):777-83. PubMed ID: 2744749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of pleural effusions by flow-cytometric DNA analysis.
    Høstmark J; Vigander T; Skaarland E
    Eur J Respir Dis; 1985 May; 66(5):315-9. PubMed ID: 4018184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry and Feulgen cytophotometry in evaluation of effusions.
    Schneller J; Eppich E; Greenebaum E; Elequin F; Sherman A; Wersto R; Koss LG
    Cancer; 1987 Apr; 59(7):1307-13. PubMed ID: 2434207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric DNA analysis of ulcerative colitis using paraffin-embedded biopsy specimens: comparison with morphology and DNA analysis of fresh samples.
    Hartmann DP; Montgomery EA; Carr NJ; Gupta PK; Azumi N
    Am J Gastroenterol; 1995 Apr; 90(4):590-6. PubMed ID: 7717317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions.
    Hasteh F; Lin GY; Weidner N; Michael CW
    Cancer Cytopathol; 2010 Apr; 118(2):90-6. PubMed ID: 20209622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.